HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.

Abstract
Sphingosine kinase 1 (SK1) catalyzes the conversion of sphingosine to the bioactive lipid sphingosine 1-phosphate. We have previously demonstrated that FTY720 and (S)-FTY720 vinylphosphonate are novel inhibitors of SK1 activity. Here, we show that (S)-FTY720 vinylphosphonate binds to a putative allosteric site in SK1 contingent on formation of the enzyme-sphingosine complex. We report that SK1 is an oligomeric protein (minimally a dimer) containing noncooperative catalytic sites and that the allosteric site exerts an autoinhibition of the catalytic site. A model is proposed in which (S)-FTY720 vinylphosphonate binding to and stabilization of the allosteric site might enhance the autoinhibitory effect on SK1 activity. Further evidence for the existence of allosteric site(s) in SK1 was demonstrated by data showing that two new FTY720 analogues (a conjugate of sphingosine with a fluorophore and (S)-FTY720 regioisomer) increased SK1 activity, suggesting relief of autoinhibition of SK1 activity. Comparisons with the SK1 inhibitor, SKi or siRNA knockdown of SK1 indicated that (S)-FTY720 vinylphosphonate and FTY720 behave as typical SK1 inhibitors in preventing sphingosine 1-phosphate-stimulated rearrangement of actin in MCF-7 cells. These findings are discussed in relation to the anticancer properties of SK1 inhibitors.
AuthorsKeng G Lim, Francesca Tonelli, Zaiguo Li, Xuequan Lu, Robert Bittman, Susan Pyne, Nigel J Pyne
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 286 Issue 21 Pg. 18633-40 (May 27 2011) ISSN: 1083-351X [Electronic] United States
PMID21464128 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Actins
  • Enzyme Inhibitors
  • Immunosuppressive Agents
  • Lysophospholipids
  • Neoplasm Proteins
  • Propylene Glycols
  • sphingosine 1-phosphate
  • Phosphotransferases (Alcohol Group Acceptor)
  • sphingosine kinase
  • Proteasome Endopeptidase Complex
  • Fingolimod Hydrochloride
  • Sphingosine
Topics
  • Actins (metabolism)
  • Allosteric Regulation (drug effects)
  • Breast Neoplasms (drug therapy, enzymology)
  • Catalytic Domain
  • Cell Line, Tumor
  • Enzyme Inhibitors (chemistry, pharmacology)
  • Female
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents (chemistry, pharmacology)
  • Lysophospholipids (metabolism)
  • Models, Chemical
  • Neoplasm Proteins (antagonists & inhibitors, metabolism)
  • Phosphotransferases (Alcohol Group Acceptor) (antagonists & inhibitors, metabolism)
  • Propylene Glycols (chemistry, pharmacology)
  • Proteasome Endopeptidase Complex (metabolism)
  • Sphingosine (analogs & derivatives, chemistry, metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: